The server is under maintenance between 08:00 to 12:00 (GMT+08:00), and please visit later.
We apologize for any inconvenience caused
Login  | Sign Up  |  Oriprobe Inc. Feed
China/Asia On Demand
Journal Articles
Laws/Policies/Regulations
Companies/Products
Bookmark and Share
ti luo fei ban lian he di fen zi gan su niao ji mei zhi liao zhong zheng ji xing que xue xing nao zu zhong
Author(s): 
Pages: 249-250
Year: Issue:  4
Journal: QILU PHARMACEUTICAL AFFAIRS

Keyword:  替罗非班重症急性缺血性脑卒中神经功能缺损评分;
Abstract: 目的 评价替罗非班在重症急性缺血性脑卒中的临床疗效.方法 选择重症急性缺血性脑卒中患者21例,采用替罗非班治疗,在入院时及治疗后两月对病人进行神经功能缺损评分并进行临床结局评定,对照组为既往类似患者.结果 治疗组病人神经功能缺损评分改善较对照组有明显差异(P<0.05),临床结局改善明显优于对照组.结论 重症急性缺血性脑卒中患者急性期使用替罗非班能促进血管再通,降低病人神经功能受损程度,改善重症卒中预后.
Related Articles
No related articles found